Adiponectin: mechanistic insights and clinical implications
By A. Turer, P. Scherer. Diabetologia, 2012
601 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Epidemiology, Physiology
View Paper: https://www.semanticscholar.org/paper/4304f9b4f0dba3e40baa9251e94c346db4029783
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
In Epidemiology
In Physiology
Citations in the corpus
- Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis Through Adipose Tissue Crosstalk (2016, background): “Adipocyte Glucose Metabolism Adiponectin: The insulin-sensitizing action of adiponectin is impressively conserved among mammals, extending from mice and humans (Turer and Scherer, 2012) to the yellow-bellied marmot and dolphin (Florant et al., 2004; Venn-Watson et al., 2013).”
- Obesity and inflammation: the linking mechanism and the complications (2016, background): “Effects of adiponectin on insulin sensitivity and peripheral tissues [114].”
- What We Talk About When We Talk About Fat (2014, unknown): “It circulates in plasma as trimers, hexamers, and higher-order structures; these larger complexes can be difficult to quantify but likely represent the most biologically active forms of the molecule (Turer and Scherer, 2012).”
- The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes. (2013, background): “, 2012), and treatment of rodents with exogenous adiponectin has been shown to augment insulin action (Berg et al., 2001; Turer and Scherer, 2012).”